Company overview
ELGA LabWater, part of Veolia Water Technologies, provides water purification systems producing Type I, II, and III pure and ultrapure water for pharmaceutical, biotechnology, and research applications. Their reliable systems deliver up to thousands of liters daily, ensuring high-quality water for experiments, testing, and analysis in labs worldwide. Products like PURELAB Chorus and Flex series optimize space and efficiency for consistent, contaminant-free results.
ELGA LabWater is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include elga labwater, water purification systems, ultrapure water pharma, lab water purifiers, type i water.
Structured facts
- Website
- https://www.elgalabwater.com/
- Markets served
- United States & Americas
- Keywords
- elga labwater, water purification systems, ultrapure water pharma, lab water purifiers, type i water
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What types of purified water do ELGA systems produce?
- ELGA systems produce Type I (ultrapure, 18.2 MΩ.cm), Type II (pure), and Type III water suitable for various lab applications including pharma and biotech.
- What industries does ELGA serve, particularly in pharma?
- ELGA serves pharmaceuticals, biotechnology, chemical, academic research, healthcare, and clinical environments requiring high-purity water.
- What are key product examples for lab water purification?
- Key products include PURELAB Chorus 1 Complete (up to 480L/day ultrapure), PURELAB Flex 3 (tap to ultrapure), and systems dispensing all three water types from one unit.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
